Enanta Pharmaceutica (ENTA) 27.03 $ENTA Forget Valeant,

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Enanta Pharmaceutica (ENTA) 27.03 $ENTA

Forget Valeant, Buy These 5 Drug Stocks Instead
Arpita Dutt - Zacks Investment Research - Thu Mar 17, 9:10AM CDT
It's time to focus on drug stocks with interesting pipelines, good prospects and favorable Zacks Ranks.
SGYP: 2.78 (+0.16), VRX: 31.09 (-2.34), SCMP: 10.20 (+0.06), ARIA: 6.55 (+0.22), ENTA: 27.03 (+0.51), CORT: 4.29 (+0.10)

Enanta Pharmaceuticals to Present at the Barclays Global Healthcare Conference
Business Wire - Thu Mar 10, 7:00AM CST
Enanta Pharmaceuticals, Inc., (NASDAQ: ENTA), a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced that Jay R. Luly, Ph.D., President and Chief Executive Officer, will participate in a fireside chat format, or question and answer session with investors, at the Barclays Global Healthcare Conference on March 17, 2016 at 11:15 a.m. ET.
ENTA: 27.03 (+0.51)

Enanta Pharmaceuticals beats 1Q profit forecasts
Automated Insights - Mon Feb 08, 3:14PM CST
WATERTOWN, Mass. (AP) _ Enanta Pharmaceuticals Inc. (ENTA) on Monday reported fiscal first-quarter earnings of $26.2 million.
ENTA: 27.03 (+0.51)

Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2015
Business Wire - Mon Feb 08, 3:02PM CST
--Royalty revenue for paritaprevir containing regimens was $17.9 million
ENTA: 27.03 (+0.51)

Enanta Pharmaceuticals to Present at the LEERINK Partners 5th Annual Global Healthcare Conference
Business Wire - Mon Feb 01, 7:00AM CST
Enanta Pharmaceuticals, Inc., (NASDAQ: ENTA), a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced that Jay R. Luly, Ph.D., President and Chief Executive Officer, will participate in a fireside chat format, or question and answer session with investors, at the LEERINK Partners 5th Annual Global Healthcare Conference on February 10, 2016 at 9:15 a.m. ET.
ENTA: 27.03 (+0.51)

Enanta Pharmaceuticals to Host Conference Call on February 8 at 4:30 p.m. ET to Discuss Financial Results for its Fiscal First Quarter Ended December 31, 2015
Business Wire - Thu Jan 28, 7:00AM CST
Enanta Pharmaceuticals, Inc., (NASDAQ: ENTA), a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced that it plans to report its financial results for its fiscal first quarter ended December 31, 2015 after the U.S. markets close on February 8, 2016. Enanta management will host a conference call at 4:30 p.m. ET to discuss these results and provide an update on Enanta's research and development pipeline.
ENTA: 27.03 (+0.51)

Enanta Pharmaceuticals Announces New R&D Initiatives in Hepatitis B Virus and Respiratory Syncytial Virus and Plan to Provide Data Updates on Programs in NASH and HCV at the 34th Annual J.P. Morgan Healthcare Conference
Business Wire - Mon Jan 11, 7:00AM CST
--First subject dosed in phase 1 clinical study with cyclophilin inhibitor EDP-494 for hepatitis C virus infection
JPM: 59.48 (-0.46), ENTA: 27.03 (+0.51)

Enanta Pharmaceuticals Announces That AbbVie Has Initiated Enrollment of Six Global Phase 3 Clinical Studies of Its Once-Daily, Pan-Genotypic Hepatitis C Treatment
Business Wire - Mon Jan 11, 6:10AM CST
--New investigational combination evaluates treatment durations of 12 weeks and as short as eight weeks in genotype 1 patients
ENTA: 27.03 (+0.51)

AbbVie Initiates Enrollment of Six Global Phase 3 Clinical Studies for Once-Daily, Pan-Genotypic Hepatitis C Regimen
PR Newswire - Mon Jan 11, 6:00AM CST
AbbVie (NYSE: ABBV), a global biopharmaceutical company, today announced the initiation of six global Phase 3 clinical studies evaluating the safety and efficacy of its all-oral, once-daily, ribavirin-free investigational hepatitis C virus (HCV) regimen, ABT-493, an NS3/4A protease inhibitor, and ABT-530, an NS5A inhibitor, in patients with genotypes 1-6 (GT1-6) chronic HCV infection.
ABBV: 56.12 (-0.24), ENTA: 27.03 (+0.51)

Enanta Pharmaceuticals Announces the U.S. FDA Grants Priority Review to AbbVie's Supplemental New Drug Application for VIEKIRA PAK(R) Without Ribavirin in Genotype 1B Chronic Hepatitis C Virus Patients with Compensated Cirrhosis
Business Wire - Thu Jan 07, 8:09AM CST
--TURQUOISE-III study showed 100 percent sustained virologic response at 12 weeks post-treatment (SVR12) in patients with genotype 1b (GT1b) chronic hepatitis C virus and compensated cirrhosis (Child-Pugh A)
ENTA: 27.03 (+0.51)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Unpacking RAGEism: Power Dynamics in U.S. Policies

Updated Category News Views 0

Seeing Patterns in Crisis: Jackson and Flint When Jackson, Mississippi's latest water crisis hit the news, it wasn't the first time folks were left high and dry. No, this fiasco's got deep roots, and it resonates with another infamous case: Flint, Michigan. In Maya Rockeymoore Cummings' book, RAGEism, these are badge-worthy examples of 'Resource Hoarding' where government...

Continue Reading
Maurices Strengthens Position with Key Refinancing Deal

Updated Category News Views 2

Maurices' Bold Financial Maneuver When a retailer like Maurices, with its near-century-long history, decides to play in the financial arena, it sure makes my ears perk up. This Duluth-based women's fashion retailer isn't just dipping its toes in—it's executing a full-blown refinancing blitzkrieg and coming out stronger. Announcing the completion of its refinancing plan...

Continue Reading
Rare Collectibles Highlight Morphy's Auction on Oct 4

Updated Category News Views 0

Anticipation Builds for Morphy's Auction Event Morphy's upcoming event on October 4th is all about tapping into the era of revved engines, gleaming gasoline signs, and some history that could put Hollywood tales to shame. The auction isn't just a stroll down memory lane; it features over 650 lots, each a time capsule of America's automotive past. From Al Capone's ritzy...

Continue Reading
AI Trust in Finance: Survey Reveals Market Impact

Updated Category News Views 1

Trust in AI for Financial Guidance: Where Are We Headed? The market winds shift with every sunrise, and today’s buzzword? Artificial Intelligence. You’d almost think AI’s trying to steal my job along with every other trader’s mojo. But here's the twist—A survey from Possible Finance shows about 15% of folks would actually lean on AI for their financial advice....

Continue Reading
Cap Juluca: Caribbean Luxury Redefined on Maundays Bay

Updated Category News Views 2

The Tranquil Call of Maundays Bay Find me dipping my toes in the sands of Maundays Bay come October 10, 2026, and you'll understand why this slice of Anguilla stakes its claim to being the best beach on the globe. Cap Juluca, that crown jewel of Caribbean luxury, swings open its doors once more, promising indulgence framed by turquoise waters and the soft whisper of white...

Continue Reading
Navigating Land Access: The Hidden Roadblock in Mining

Updated Category News Views 0

Mining's Often Overlooked Obstacle: Land Access In the world of mining, the shallow thrills of striking gold are often overshadowed by the frustrating slog of securing land access. You can have your permits lined up, your finances sorted, and drills humming along, but if you haven’t sweet-talked the folks farming above your visible vein of riches, you could be staring...

Continue Reading
Albertsons Welcomes Once Upon a Coconut Nationwide

Updated Category News Views 0

Coconut Water Takes Over Grocery Aisles You know, for all the cautious optimism I wield, this here is a move that shows real muscle in the world of coconut water—I mean, slamming into Albertsons' grocery empire is no small potatoes! Once Upon a Coconut has landed its premium hydration cans across all the banners under this giant retailer. From that good ol' familiar...

Continue Reading
Cannabis Industry Pushes for Robust Financial Services

Updated Category News Views 0

Industry Gears Up for Financial Action Clearly, cannabis businesses are shouting louder than a vendor at a ballgame, demanding more than just the basic chips-and-soda banking service. They’re on the hunt for serious credit facilities, payments, and the traditional financial tools that most sectors take for granted. I mean, check this out: Shield Compliance just dropped...

Continue Reading
WNET's 25th Anniversary 9/11 Tribute: Stories and Lessons

Updated Category News Views 3

Reflecting on a Dark Day with WNET's Programming Nothing quite hits you like the anniversary of a colossal tragedy. The memories of September 11, 2001, remain etched in the urban landscape of New York City, and this year marks 25 years since that heart-wrenching day. The WNET Group steps up to the plate with a comprehensive slate of programming aimed at honoring the...

Continue Reading
Tampa General’s Innovation Excellence Earns No. 20 Spot

Updated Category News Views 7

A Bold Leap into Innovation at Tampa General There's a heck of a lot going on down in Tampa that's worth more than just a golf clap. Tampa General Hospital (TGH) just snagged the 20th spot on Fast Company's Best Workplaces for Innovators list, and let me tell you, that’s no small feat amidst the heavy hitters in verticals like biotech and consumer goods. It takes guts...

Continue Reading

Top 5 Most Recently Viewed Articles

Columbus McKinnon Announces Exciting Dividend for Shareholders

Updated Category News Views 105

Columbus McKinnon Announces Quarterly Dividend Columbus McKinnon Corporation (NASDAQ: CMCO), known for its innovative intelligent motion solutions in material handling, has declared a quarterly dividend of $0.07 per share. The Board of Directors has made this decision, showcasing the company's ongoing commitment to returning value to its shareholders. Timing of the...

Continue Reading
Amundi Physical Gold ETC Expands Issuance with New Securities

Updated Category News Views 123

Amundi Physical Gold ETC Launches New Tranche of Securities Amundi Physical Metals plc is enhancing its presence in the gold market by launching a new tranche of ETC Securities. This issuance comprises 88,400 new ETC Securities and is part of Tranche 636 under its Secured Precious Metal Linked ETC Securities Programme. This strategic move aims to increase the total number...

Continue Reading
Understanding the Unique Value Proposition of Trump Media

Updated Category News Views 140

Reevaluating the Value Proposition of Trump Media & Technology Trump Media & Technology (NASDAQ: DJT) represents an unconventional player in the public market landscape. Unlike typical media companies, DJT operates within a unique framework, making traditional valuation methods less effective. This distinctive behavior means that the stock does not always correlate with...

Continue Reading
Osisko Metals Unveils Impressive Drill Results at Gaspé Project

Updated Category News Views 112

Osisko Metals Announces Promising Drill Results Osisko Metals Incorporated (the “Company” or "Osisko Metals") (TSX-V: OM; Other OTC: OMZNF; Frankfurt: 0B51) is thrilled to share exciting updates from its Gaspé Copper Project. These results highlight the continued success of the drilling program, which has recently surpassed expectations with impressive mineralization...

Continue Reading
Doceree Integrates AI-Powered Solution with Epic for HCPs

Updated Category News Views 250

Doceree Integrates Spark with Epic for Enhanced HCP Engagement Doceree has made a significant stride in the healthcare digital landscape by integrating its innovative AI-powered solution, Spark, with Epic, a leading electronic health record (EHR) system. This integration is positioned to revolutionize how healthcare professionals (HCPs) interact within EHR platforms,...

Continue Reading